Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
达拉非尼联合曲美替尼对比纳武利尤单抗联合伊匹木单抗治疗晚期BRAF突变型黑色素瘤患者:DREAMseq试验-ECOG-ACRIN EA6134
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01763
Atkins, Michael B; Lee, Sandra J; Chmielowski, Bartosz; Tarhini, Ahmad A; Cohen, Gary I; Truong, Thach-Giao; Moon, Helen H; Davar, Diwakar; O'Rourke, Mark; Stephenson, Joseph J; Curti, Brendan D; Urba, Walter J; Brell, Joanna M; Funchain, Pauline; Kendra, Kari L; Ikeguchi, Alexandra P; Jaslowski, Anthony; Bane, Charles L; Taylor, Mark A; Bajaj, Madhuri; Conry, Robert M; Ellis, Robert J; Logan, Theodore F; Laudi, Noel; Sosman, Jeffrey A; Crockett, David G; Pecora, Andrew L; Okazaki, Ian J; Reganti, Sowjanya; Chandra, Sunandana; Guild, Samantha; Chen, Helen X; Streicher, Howard Z; Wolchok, Jedd D; Ribas, Antoni; Kirkwood, John M